1LLY:BIT
Eli Lilly And Co
1 017,40 €
arrow_downward
-0,57%(-5,80) 1 d.
2. 10., 17:29:23 GMT+2 · EUR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre 1LLY…
Otvoriť
1 023,60 €
Vysoká
1 031,00 €
Nízka
1 016,00 €
Trh. kap.
1,11 bil.
Priem. obj.
382,00
Objem
492,00
Max. za 52 týž.
1 106,80 €
Min. za 52 týž.
640,70 €
Počet zamestnancov
50 tis.
Otvoriť
1 023,60 €
Vysoká
1 031,00 €
Nízka
1 016,00 €
Trh. kap.
1,11 bil.
Priem. obj.
382,00
Objem
492,00
Max. za 52 týž.
1 106,80 €
Min. za 52 týž.
640,70 €
Počet zamestnancov
50 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
The Globe and Mail
·
pred 5 hodinami
4 Healthcare Stocks Worth Owning for the Next Decade
Investing.com Canada
·
pred 6 hodinami
RBC Capital reiterates Eli Lilly stock rating on incretin momentum By Investing.com
The Motley Fool
·
pred 6 hodinami
This Drug Combination for Eli Lilly Generated Significantly More Weight Loss Than Just Zepbound, but Discontinuation Rates Were Also Far Higher. Here's What This Could Mean for the Stock
marketscreener.com
·
pred 7 hodinami
Eli Lilly Likely to Raise Revenue Outlook Amid Strong Diabetes, Weight-Loss Drug Sales, RBC Says
Profil
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 36 countries. Its products are marketed in approximately 90 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
Informácie o subjekte Eli Lilly And Co
Generálny riaditeľDavid A. Ricks
Zamestnanci50 tis.
Dátum založenia1876
Hlavné sídloIndianapolis, Indiana, Spojené štáty americké
Odvetvie-
Weblilly.com